NHL Survivor hits 3 year mark

In his driveway four years ago, Joseph Khoury discovered he couldn't move his legs or get out of his car. Only 24 years old then, he had no idea he was stricken with non-Hodgkin's lymphoma. "We had a lot of red flags of cancer: not sleeping, muscle pains, sweating when he slept. But we just thought he was out of shape and overweight," said his wife Tracie, a chiropractor, who at the time was finishing school.



In late March 2001, her husband had been complaining of a swelling in his neck. She phoned Joseph and told him to meet her at the doctor's office. Awaiting the doctor, Tracie noticed that her husband's left arm had turned wine red and his fingers were swollen. "He knew something was blocking the blood flow," Joseph said. "X-rays showed a massive tumor." The morning after, a CT scan showed Joseph likely had lymphoma, and a melon-sized tumor behind his sternum cut off blood flow. A week later, Joseph was diagnosed with an advanced stage of non-Hodgkin's lymphoma.



After chemotherapy, by Halloween 2001, Joseph's cancer was in remission. A few days later, he and Tracie were aboard a cruise for a honeymoon. "The first doctor told us to wait five years after chemo until we have children," Joseph said. "But now it's being discussed again. We want to have kids. That's why we just purchased a bigger home." Full Article

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap